1. Bioorg Med Chem Lett. 2006 Sep 15;16(18):4922-30. doi: 
10.1016/j.bmcl.2006.06.049. Epub 2006 Jul 7.

Synthesis and structure-activity relationships of retro bis-aminopyrrolidine 
urea (rAPU) derived small-molecule antagonists of the melanin-concentrating 
hormone receptor-1 (MCH-R1). Part 2.

Hudson S(1), Kiankarimi M, Rowbottom MW, Vickers TD, Wu D, Pontillo J, Ching B, 
Dwight W, Goodfellow VS, Schwarz D, Heise CE, Madan A, Wen J, Ban W, Wang H, 
Wade WS.

Author information:
(1)Department of Medicinal Chemistry, Neurocrine Biosciences Inc., 12790 El 
Camino Real, San Diego, CA 92130, USA. shudson@neurocrine.com

The design, synthesis, and SAR of a series of retro bis-aminopyrrolidine ureas 
are described. Compounds from this series exhibited considerable binding 
affinity (Ki = 1 nM) and functional activity at MCH-R1, acceptable CYP2D6 
inhibition, and good rat brain exposure.

DOI: 10.1016/j.bmcl.2006.06.049
PMID: 16824755 [Indexed for MEDLINE]
